openPR Logo
Press release

Creative Diagnostics Announces the Launch of Its Highly Sensitive Kanamycin ELISA Kit for Precise Antibiotic Detection

03-25-2024 07:36 PM CET | Health & Medicine

Press release from: ABNewswire

Creative Diagnostics Announces the Launch of Its Highly

Creative Diagnostics announces the launch of its Kanamycin ELISA Kit.
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the launch of its cutting-edge Kanamycin ELISA Kit [https://www.creative-diagnostics.com/Kanamycin-ELISA-Kit-3589-464.htm]. This innovative kit enables the rapid and accurate detection of kanamycin residues in various biological products.

Biopharmaceuticals are a class of drugs that are typically produced in living organisms and can be used to treat a wide range of diseases. Biopharmaceutical samples include hormones, enzymes, monoclonal antibodies, vaccines, and blood factors, each of which face different challenges during drug development and production, including process-related residual impurities and their levels in the final biopharmaceutical product.

The use of appropriate concentrations of antibiotics during cell culture can prevent contamination as well as morphological or physiological changes caused by contamination. In addition, certain antibiotics are used to screen transfected/transgenic cells. Therefore, antibiotics are common cell culture-derived impurities in biomanufacturing processes.

Kanamycin or Kanamycin A is a bactericidal aminoglycoside antibiotic available in oral, intravenous and intramuscular forms for the treatment of a wide range of infections and tuberculosis. Kanamycin is isolated from Streptomyces kanamycinensis and its most commonly used form is kanamycin sulfate. It is commonly used as an antibiotic in cell culture processes. Due to the potent effects of kanamycin on humans during the manufacturing process and in the finished drug product, regulatory agencies around the world have limited and quantified kanamycin residues. Residues of kanamycin during the manufacture of biologics can cause abnormal reactions in humans and therefore strict MRLs have been established.

Creative Diagnostics now provides researchers with a rapid, accurate, and easy-to-use method for detecting kanamycin residues in biological products. The analytical sensitivity of the Kanamycin ELISA kit has been determined to be 0.5 ng/mL. The standards / linear graph range is 0.5-40.5 ng/mL. It allows precise measurement of Kanamycin levels in various samples and can greatly reduce the operator error in the detection process.

This ELISA kit has been designed for the detection of Kanamycin based on the principle of the "indirect competitive" enzyme immunoassay. The microtiter plate is coated with a capture antigen linked to BSA. Kanamycin in the sample competes with the antigen on the microplate for antibodies. After addition of the enzyme conjugate, chromogenic substrate is used and the signal is measured by spectrophotometer. The absorbance is inversely proportional to the concentration of kanamycin in the sample. It is noted that this kit is for research and laboratory use only and is not intended for diagnostic, therapeutic, drug, home or other usage.

Creative Diagnostics offers Kanamycin ELISA Kit for the quantitative and qualitative analysis of kanamycin residues in biological samples. For more information on the new product, please visit https://www.creative-diagnostics.com/Kanamycin-ELISA-Kit-3589-464.htm.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers' assay development and manufacturing needs.

Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=creative-diagnostics-announces-the-launch-of-its-highly-sensitive-kanamycin-elisa-kit-for-precise-antibiotic-detection]
State: New York
Country: United States
Website: https://www.creative-diagnostics.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Creative Diagnostics Announces the Launch of Its Highly Sensitive Kanamycin ELISA Kit for Precise Antibiotic Detection here

News-ID: 3441530 • Views:

More Releases from ABNewswire

Rhino Rescue's Quality Pledge: Unveiling the Extreme Resilience of Core Components
Rhino Rescue's Quality Pledge: Unveiling the Extreme Resilience of Core Componen …
Discover Rhino Rescue's quality pledge through our extreme component testing. See why our tactical gear is built to perform. Our Commitment and Responsibility In the life and death arena of emergency response, where seconds matter, the dependability of your equipment is absolute. It is a fact that has been guiding our mission since our parent company, Nanchi Medical, was established in 2010. Having a 14-year history in the first aid industry and
Tampa SEO Launches Cutting-Edge Local Search Optimization Services to Help Tampa Bay Businesses Dominate Google Rankings
Tampa SEO Launches Cutting-Edge Local Search Optimization Services to Help Tampa …
Tampa SEO, a full-service digital marketing agency based in Tampa Bay, today announced the official launch of its enhanced SEO and digital marketing services at http://tampa-seo.net. The company specializes in helping local businesses increase their online visibility, generate qualified leads, and outperform competitors through data-driven, ethical search engine optimization strategies. Helping Local Businesses Thrive in the Digital Age With nearly 97% of consumers searching online for local services before making a purchase,
Fibromyalgia Market Expected to Gain Momentum Through 2034, According to DelveInsight | UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, Tonix Pharma, UCB Biopharma SRL, GSK
Fibromyalgia Market Expected to Gain Momentum Through 2034, According to DelveIn …
The Key Fibromyalgia Companies in the market include - Tonix Pharmaceutical, UCB Biopharma SRL, GlaxoSmithKline, UCB Pharma, Pierre Fabre Medicament, UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, AstraZeneca, RiboCor, Inc., Bial - Portela C S.A, and others. DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States,
DMB Plumbing & Heating Urges Homeowners to Schedule Pre-Winter Heating Inspections
DMB Plumbing & Heating Urges Homeowners to Schedule Pre-Winter Heating Inspectio …
DMB Plumbing & Heating Inc. of Bridgewater, led by Dean Blanchard, is urging homeowners to schedule pre-winter heating inspections. As temperatures in Massachusetts begin to dip and residents prepare their homes for another New England winter, DMB Plumbing & Heating Inc., a locally owned and operated company based in Bridgewater, is reminding homeowners of the importance of pre-winter heating inspections. Founded and operated by Dean Blanchard, DMB Plumbing & Heating has long

All 5 Releases


More Releases for Kanamycin

Kanamycin Market is Anticipated to Record the Rapid Growth and Prominent Players …
This Kanamycin market report is based on firsthand knowledge, descriptive and inferential statistical analysis by industry analysts, and contributions from industry experts and stakeholders all across value chain. This report examines parent industry trends, macroeconomic data, and governing factors in depth, as well as market attractiveness by sector. We provide high-level reports that shed insight into the current state of several industrial verticals as well as COVID -19 scenario. The
Kanamycin Sulfate Market 2023Key market Insights, Drivers and Restraints, Opport …
A global Kanamycin Sulfate market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading players' various strategies to sustain in the global market. This report covers five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data. Apart from this, the report also covers detailed information about
Aminoglycosides Market Growth Insights, Business Opportunities Forecast To 2028
Precision Business Insights published a research report on "Aminoglycosides Market: By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Other Aminoglycosides), Mode of Administration (Feed, Injectables, Intra-mammary, Topical, Oral), Applications (Veterinary, Skin, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others - Global/Region/Country Forecast to 2028" Aminoglycosides are antibiotics with a broad spectrum of action that block protein synthesis that are used to treat
Kanamycin Market to Witness Huge Growth by Key Players: Thermo Fisher, HiMedia, …
The Kanamycin research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the Kanamycin industry to
Global Kanamycin Market Is Likely to Witness Tremendous Growth by 2025: Key Play …
UpMarketResearch offers a latest published report on “Global Kanamycin Market Research Report 2019” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 95 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Request Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/67139 Kanamycin Market research report delivers a close watch on leading competitors with strategic
Kanamycin Market Research Report 2019-2026 | Top Key Players – Thermo Fisher, …
UpMarketResearch offers a latest published report on “Global Kanamycin Market Analysis and Forecast 2019-2026” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 112 which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/48372 Kanamycin Market research report delivers a close watch on leading